Neal Rosen

Also affiliated with Kettering University, Organogenesis (United States)

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 36 papers. Top paper: “MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions”.

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100256

N/A

0.396DataRank · unranked

13 citations

Eusebio Manchado, Matthew J. Bott, Linda S. Ahn, Yosef Y. Tobi, Andy Ai Ni +14 more

Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0865

N/A

0DataRank · unranked

31 citations

Brooke E. Sylvester, Matthew T. Chang, Arijh Elzein, Jianjiong Gao, Weiwei Han +24 more

Mutant-selective Degradation by BRAF-targeting PROTACs

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.10.245159

N/A

0DataRank · unranked

14 citations

Saul Jaime‐Figueroa, Zhan Yao, Yijun Gao, John Hines, Kusal T. G. Samarasinghe +4 more

Anatomic position determines oncogenic specificity in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.14.383083

N/A

0DataRank · unranked

13 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Anti-tumor effects of an Id antagonist with no acquired resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.06.894840

N/A

0DataRank · unranked

3 citations

Marta Garcia Escolano, Yun-Han Huang, Bina Desai, Yvette Chin, Riddhi Shah +18 more

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1726

N/A

0DataRank · unranked

166 citations

Baishan Jiang, Jiaye Guo, Hong Shao, Isabella Del Priore, Qing Chang +20 more

Mutant-selective degradation by BRAF-targeting PROTACs

Nature Communications(2021)10.1038/s41467-021-21159-7

N/A

0DataRank · unranked

138 citations

Saul Jaime‐Figueroa, Zhan Yao, Yijun Gao, John Hines, Kusal T. G. Samarasinghe +4 more

Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis

Molecular Cell(2021)10.1016/j.molcel.2021.01.033

N/A

0DataRank · unranked

135 citations

Kiran Vanaja, Jacob A. Boyer, Sunyana Gadal, Hilla Solomon, Sarat Chandarlapaty +3 more

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway

Nature Communications(2021)10.1038/s41467-021-27093-y

N/A

0DataRank · unranked

88 citations

Emanuela Ferraro, Anton Safonov, Cristina Bernadó Morales, Enrique J. Arenas, Qing Li +10 more

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4189

N/A

0DataRank · unranked

54 citations

Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa +18 more

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers

Nature Communications(2021)10.1038/s41467-021-25341-9

N/A

0DataRank · unranked

30 citations

Zeda Zhang, Young Sun Lee, Danielle Choi, Aura Agudelo Rivera, Dan Li +13 more

Anti-tumor effects of an ID antagonist with no observed acquired resistance

npj Breast Cancer(2021)10.1038/s41523-021-00266-0

N/A

0DataRank · unranked

29 citations

Marta Garcia Escolano, Yun-Han Huang, Bina Desai, Yvette Chin, Riddhi Shah +22 more

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

Nature Chemical Biology(2021)10.1038/s41589-021-00843-1

N/A

0DataRank · unranked

2 citations

Jacob A. Boyer, G. Leslie Burnett, Arun P. Thottumkara, Nidhi Tibrewal, Stacy Wilson +21 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0DataRank · unranked

140 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Anatomic position determines oncogenic specificity in melanoma

Nature(2022)10.1038/s41586-022-04584-6

N/A

0DataRank · unranked

99 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1631

N/A

0DataRank · unranked

36 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1

Molecular Cell(2022)10.1016/j.molcel.2022.04.034

N/A

0DataRank · unranked

23 citations

Radha Mukherjee, Rona Yaeger, Jieun Son, Jianing Xu, Na Na +22 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.21.568071

N/A

0DataRank · unranked

1 citations

Jacob A. Boyer, Simon F. Roy, Noah A. Outmezguine, Malvika Sharma, Hongyan Li +14 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965.v1

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

(2023)10.1158/2159-8290.c.6549783

N/A

0DataRank · unranked

0 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

BRAF — a tumour-agnostic drug target with lineage-specific dependencies

Nature Reviews Clinical Oncology(2024)10.1038/s41571-023-00852-0

N/A

0DataRank · unranked

125 citations

Ziyu Chen, Neal Rosen, David B. Solit, Aphrothiti J. Hanrahan

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

Nature Communications(2024)10.1038/s41467-024-50063-z

N/A

0DataRank · unranked

35 citations

Philip H. Choi, Yu Chi Yang, Jacob A. Boyer, Adele Whaley, Priya Pancholi +16 more

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3981

N/A

0DataRank · unranked

12 citations

Soo‐Ryum Yang, Jessica J. Tao, Antoine Desîlets, Eli L. Diamond, Clare Wilhelm +18 more

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101818

N/A

0DataRank · unranked

4 citations

Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.08.593195

N/A

0DataRank · unranked

2 citations

Malvika Sharma, M. Dorso, Nicholas Mai, Corina Amor, Jason Reiter +21 more

Diet induced insulin resistance is due to induction of PTEN expression

Research Square(2024)10.21203/rs.3.rs-4021885/v1

N/A

0DataRank · unranked

0 citations

Radha Mukherjee, Priya Pancholi, Malvika Sharma, Hilla Solomon, Merna N. Timaul +11 more

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0614

N/A

0DataRank · unranked

12 citations

Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra +19 more

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2424286122

N/A

0DataRank · unranked

9 citations

Ezra Y. Rosen, Malvika Sharma, M. Dorso, Nicholas Mai, Corina Amor +22 more

RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition

Cancer Cell(2025)10.1016/j.ccell.2025.09.014

N/A

0DataRank · unranked

3 citations

Jean‐François Emile, T Fujino, Julien Haroche, Maxim I. Maron, Alexander M. Lewis +40 more

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0187

N/A

0DataRank · unranked

493 citations

Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato +24 more

Targeting mTORC1 to promote ferroptosis and apoptosis in endometrial cancer with PI3K-Akt-mTOR pathway mutation

Ferroptosis and Oxidative Stress(2025)10.70401/fos.2025.0005

N/A

0DataRank · unranked

2 citations

Pei Liu, Neal Rosen, Xuejun Jiang, Yingying Hu

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more